Transanal total mesorectal excision and low anterior resection syndrome

Autor: Mathijs P. Hendriks, J M van Dodewaard-de Jong, J W T Dekker, J.A.G. van der Heijden, Bastiaan R. Klarenbeek, A J G Maaskant-Braat, D J A Sonneveld, T van Voorthuizen, Hein B.A.C. Stockmann, L B J Valkenburg-van Iersel, I.H.J.T. de Hingh, F W H Kloppenberg, G R Vink, Seyed M. Qaderi, F H Beverdam, K Talsma, A H W Schiphorst, J F J Vogelaar, Frans L. G. Erdkamp, H W M U van Grevenstein, W J Vles, Marco B. Polee, Jan B.M.J. Jansen, H H Helgason, P P L O Coene, Geerard L. Beets, E J Th Belt, A U G van Lent, Jan N. M. IJzermans, D D E Zimmerman, M L R Tjin-A-Ton, A J ten Tije, M Berbée, Leonie J. M. Mekenkamp, M P S Sie, Annebeth W. Haringhuizen, Koen C.M.J. Peeters, Maartje Los, A M T van der Velden, N A J B Peters, J W B de Groot, Martijn R. Meijerink, A Schouten van der Velden, A I de Vos, J.H.W. de Wilt, Lieke H.J. Simkens, E G G Verdaasdonk, José A. E. Custers, Peter Nieboer, Rob H.A. Verhoeven, M Vermaas, F Terheggen, P Quarles van Ufford-Mannesse, R Blankenburgh, R Hoekstra, R W M Schrauwen, Dirkje W. Sommeijer, R C Rietbroek, H van Cruijsen, L E A Spierings

Publikováno v: British journal of surgery, 108(8), 991-997. John Wiley and Sons Ltd
British Journal of Surgery, 108(8), 991-997. Wiley
PLCRC group 2021, ' Transanal total mesorectal excision and low anterior resection syndrome ', British Journal of Surgery, vol. 108, no. 8, pp. 991-997 . https://doi.org/10.1093/bjs/znab056
British Journal of Surgery, 108, 8, pp. 991-997
British Journal of Surgery, 108, 991-997
British Journal of Surgery, 108(8), 991-997. John Wiley and Sons Ltd

Background Bowel dysfunction after rectal cancer surgery is common, with some experiencing low anterior resection syndrome (LARS) is common after rectal cancer surgery. This study examined if transanal total mesorectal excision (TaTME) has a similar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1fcf9a92def7659b2c98d0089aa720
http://www.scopus.com/inward/record.url?scp=85116172373&partnerID=8YFLogxK

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Preferences to Receive Unsolicited Findings of Germline Genome Sequencing in a Large Population of Cancer Patients

Autor: Roel H. P. Wouters, Petronella O. Witteveen, Joan B. Heijns, Annelien L. Bredenoord, Neeltje Steeghs, Emile E. Voest, Martijn P. Lolkema, D. ten Bokkel Huinink, T. van Voorthuizen, Hester Wessels, H. van Cruijsen, A. M. May, Laurens V. Beerepoot, Annelie J. Vulink, Stefan Sleijfer, Margreet G. E. M. Ausems, Rhodé M Bijlsma

Publikováno v: SSRN Electronic Journal.

Background: In precision medicine, somatic and germline DNA sequencing are essential to make genome-guided treatment decisions in cancer patients. However, it can also uncover unsolicited findings (UFs) in germline DNA that could have a substantial i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::592d8e8102e720950682af6aed7a94a3
https://doi.org/10.2139/ssrn.3300451

Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity

Autor: T.D. de Gruijl, Cynthia M. Fehres, H. van Cruijsen, Jelle J. Lindenberg, Dinja Oosterhoff

Publikováno v: Immunotherapy, 3(1), 77-96. Future Medicine Ltd.
Lindenberg, J J, Fehres, C M, van Cruijsen, H, Oosterhoff, D & de Gruijl, T D 2011, ' Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity ', Immunotherapy, vol. 3, no. 1, pp. 77-96 . https://doi.org/10.2217/imt.10.95

Myeloid differentiation is often disturbed in cancer, leading to reduced frequencies of immunostimulatory dendritic cells and an over-representation of immunosuppressive immature myeloid cells, granulocytes and macrophages. As a result of this skewed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b912021050af35569d70762fc6a0a5b3
https://research.vumc.nl/en/publications/ce5ddbab-ae27-4d65-9a9d-1bf66861c4d1

Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor

Autor: G. Giaccone, Bart C. Kuenen, R.J. Scheper, Klaas Hoekman, T.D. de Gruijl, A.J.M. van den Eertwegh, Anita G.M. Stam, H. van Cruijsen

Publikováno v: Clinical and Developmental Immunology
Van Cruijsen, H, Hoekman, K, Stam, A G M, Van Den Eertwegh, A J M, Kuenen, B C, Scheper, R J, Giaccone, G & De Gruijl, T D 2007, ' Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor ', Clinical and Developmental Immunology, vol. 2007, 17315 . https://doi.org/10.1155/2007/17315
Clinical and Developmental Immunology, Vol 2007 (2007)
Clinical and Developmental Immunology, 2007:17315. Hindawi Publishing Corporation

Tumor-derived vascular endothelial growth factor (VEGF) has previously been identified as a causative factor in the disturbed differentiation of myeloid dendritic cells (DC) in advanced cancer patients. Here, we investigated the potential of vascular

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0c4b472f42b26f0a212fd6c7b3a9e2c
https://pubmed.ncbi.nlm.nih.gov/18320010